Clincosm LogoSign in Get a demo

immunoglobulin a nephropathy

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunoglobulin A Nephropathy Trial in Denver (Sparsentan)

Not yet recruiting
  • Immunoglobulin A Nephropathy
  • Denver, Colorado
    Travere Investigational Site
May 12, 2023

IgA Nephropathy, Immunoglobulin A Nephropathy Trial (BION-1301, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • (no location specified)
May 2, 2023

IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • (no location specified)
Apr 27, 2023

Lupus Nephritis, Immunoglobulin A Nephropathy, Membranous Nephropathy Trial (povetacicept)

Not yet recruiting
  • Lupus Nephritis
  • +2 more
  • (no location specified)
Feb 16, 2023

Lupus Nephritis, Immunoglobulin A Nephropathy, IgAN Trial in United States (ALXN2050, Placebo)

Recruiting
  • Lupus Nephritis
  • +3 more
  • Huntsville, Alabama
  • +49 more
Jan 25, 2023

Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy Trial in Worldwide (Sparsentan)

Recruiting
  • Focal Segmental Glomerulosclerosis
  • +4 more
  • Wilmington, Delaware
  • +32 more
Jan 10, 2023

IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome Trial in Worldwide (Atrasentan)

Recruiting
  • IgA Nephropathy
  • +5 more
  • Huntsville, Alabama
  • +37 more
Dec 1, 2022

IgA Nephropathy, Immunoglobulin A Nephropathy Trial in Worldwide (Atrasentan, Placebo)

Recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • Birmingham, Alabama
  • +119 more
Aug 17, 2022

Immunoglobulin A Nephropathy, Kidney Diseases, Glomerulonephritis, IGA Trial in Leicester (Sparsentan)

Recruiting
  • Immunoglobulin A Nephropathy
  • +5 more
  • Leicester, United Kingdom
    Leicester General Hospital, University Hospitals of Leicester NH
May 18, 2022

Humanistic Burden of Focal Segmental Glomerulosclerosis and IgAN

Recruiting
  • Focal Segmental Glomerulosclerosis
  • Immunoglobulin A Nephropathy
    • Belmar, New Jersey
    • +2 more
    Apr 12, 2022

    Immunoglobulin A Nephropathy Trial in New York (Sibeprenlimab 400 mg, Placebo)

    Recruiting
    • Immunoglobulin A Nephropathy
    • Sibeprenlimab 400 mg
    • Placebo
    • New York, New York
      For additional information regarding sites, contact 844-687-8522
    Mar 25, 2022

    Immunoglobulin A Nephropathy, Glomerular Disease, IgAN Trial in Worldwide (Dose-Placebo, Low Dose-VIS649, Medium Dose-VIS649)

    Active, not recruiting
    • Immunoglobulin A Nephropathy
    • +2 more
    • Dose-Placebo
    • +3 more
    • Birmingham, Alabama
    • +92 more
    Mar 24, 2022

    Immunoglobulin A Nephropathy Trial in New York (Sibeprenlimab 400 mg s.c. Q4weeks)

    Not yet recruiting
    • Immunoglobulin A Nephropathy
    • Sibeprenlimab 400 mg s.c. Q4weeks
    • New York, New York
      For additional information regarding sites, contact 844-687-8522
    Feb 18, 2022

    Immunoglobulin A Nephropathy Trial (SM101, Placebo)

    Withdrawn
    • Immunoglobulin A Nephropathy
    • SM101
    • Placebo
    • (no location specified)
    Feb 3, 2022

    The Genital Tract Microflora in Systemic Lupus Erythematosus and

    Enrolling by invitation
    • Systemic Lupus Erythematosus
    • Immunoglobulin A Nephropathy
    • Smear
    • Warsaw, Poland
      Dept. of Immunology, Transplantology and Internal Medicine Trans
    Nov 22, 2021

    Glomerulonephritis, Immunoglobulin A Nephropathy Trial (Corticosteroid, Renin-angiotensin sytem blockers, Sodium-glucose

    Not yet recruiting
    • Glomerulonephritis
    • Immunoglobulin A Nephropathy
    • (no location specified)
    Oct 13, 2021

    Immunoglobulin A Nephropathy, IgAN - IgA Nephropathy, IgA Nephropathy Trial in Glendale (VIS649, Placebo)

    Completed
    • Immunoglobulin A Nephropathy
    • +2 more
    • VIS649
    • Placebo
    • Glendale, California
      California Clinical Trials Medical Group
    Mar 5, 2020

    Immunoglobulin A Nephropathy, Healthy Subjects Trial in Davis (Fish Oil)

    Completed
    • Immunoglobulin A Nephropathy
    • Healthy Subjects
    • Fish Oil
    • Davis, California
      University of California Davis
    May 25, 2017

    Immunoglobulin A Nephropathy Trial in Sweden, United States (CCX168)

    Completed
    • Immunoglobulin A Nephropathy
    • Palo Alto, California
    • +5 more
    Dec 19, 2016